WallStreetZenWallStreetZen

NASDAQ: AVTX
Avalo Therapeutics Inc Stock Ownership - Who owns Avalo Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Avalo Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Christopher Ryan SullivanChief Financial Officer2026-04-308,457$13.23
$111.85kSell
Christopher Ryan SullivanChief Financial Officer2026-04-298,458$13.09
$110.73kSell
Mittie DoyleChief Medical Officer2026-04-063,970$12.65
$50.22kBuy
Mittie DoyleChief Medical Officer2026-04-063,970$18.01
$71.51kSell
Christopher Ryan SullivanChief Financial Officer2026-04-026,200$17.03
$105.55kSell
Christopher Ryan SullivanChief Financial Officer2026-04-021,780$17.57
$31.27kSell
Christopher Ryan SullivanChief Financial Officer2026-04-01500$15.86
$7.93kSell
Christopher Ryan SullivanChief Financial Officer2026-04-017,479$16.83
$125.84kSell
Mittie DoyleChief Medical Officer2026-04-01679$8.04
$5.46kBuy
Mittie DoyleChief Medical Officer2026-04-01679$16.00
$10.86kSell

1 of 3

AVTX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AVTX insiders and whales buy or sell their stock.

AVTX Shareholders

What type of owners hold Avalo Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Armistice Capital LLC226.50%51,615,185$839.26MInsider
Robert Moscato Jr.39.29%8,952,643$145.57MInsider
Randal Jones27.91%6,359,900$103.41MInsider
Steven Boyd10.29%2,345,714$38.14MInsider
Patrick J. Crutcher7.17%1,634,771$26.58MInsider
Bvf Inc5.95%1,355,257$22.04MInstitution
Nantahala Capital Management LLC5.42%1,235,000$20.08MInstitution
Orbimed Advisors LLC5.21%1,187,300$19.31MInstitution
Affinity Asset Advisors LLC4.61%1,051,054$17.09MInstitution
Caligan Partners LP3.87%881,533$14.33MInstitution

1 of 3

AVTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AVTX19.65%80.35%Net SellingNet Selling
ASMB52.43%47.57%Net SellingNet Selling
CBIO24.78%75.22%Net Buying
XOMA19.42%80.58%Net SellingNet Buying
UPB73.77%26.23%Net SellingNet Selling
View Top Biotech Stocks

Avalo Therapeutics Stock Ownership FAQ

Who owns Avalo Therapeutics?

Avalo Therapeutics (NASDAQ: AVTX) is owned by 87.26% institutional shareholders, 356.77% Avalo Therapeutics insiders, and 0.00% retail investors. Armistice Capital LLC is the largest individual Avalo Therapeutics shareholder, owning 51.62M shares representing 226.50% of the company. Armistice Capital LLC's Avalo Therapeutics shares are currently valued at $1.13B.

If you're new to stock investing, here's how to buy Avalo Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.